The National Agency for Food and Drug Administration and Control says local production of medicines and medical devices has risen sharply following regulatory reforms aimed at boosting domestic manufacturing.
Director General of NAFDAC, Professor Mojisola Adeyeye, said the agency approved 161 facility layout submissions by October 2025, covering 96 new companies and 65 existing ones, including six medical device manufacturers.
She said policies such as the 5 plus 5 Regulatory Directive and the Ceiling List have expanded products reserved for local production, with over 70 percent now made in Nigeria.
According to Adeyeye, the reforms have improved the import to local production ratio from 70 30 in 2019 to 60 40 in 2025.
On enforcement, NAFDAC recorded 114 arrests last year and says it has adopted a risk based, intelligence driven approach aligned with global best practices.
